Preview

Meditsinskiy sovet = Medical Council

Advanced search

STARTING ANTIMICROBAL PYELONEPHRITIS THERAPY BEFORE SURGICAL THERAPY OF THE URINARY BLADDER THERAPY

https://doi.org/10.21518/2079-701X-2016-9-92-95

Abstract

Acute pyelonephritis belongs to the wide-spread inflammatory diseases in the oncourological inpatient clinic. Escherichia coli continues to be the leading causal agent of urinary tract infections. Obstructive uropathies (including urinary bladder tumours), foreign bodies, vesico-ureteral reflux contribute to ascending development of the urinary tract infection. The choice of the antimicrobial drug in the majority of cases is done speculatively, on the basis of data about domineering causative agents and their regional resistance. In case of complicated pyelonephritis the duration of the antimicrobial therapy must be 7-14 (sometimes up to 21) days. The drugs of choice for the starting empirical therapy of the complicated pyelonephritis are fluoroquinolones (ciprofloxacin, ofloxacin and levofloxacin), ticarcillin/clavulanate, third generation cephalosporins, aminoglucosides, ertapenem.

About the Authors

A. D. KAPRIN
National Medical Research Radiological Center of the Ministry of Health of Russia, Moscow
Russian Federation
MD, Prof.


A. A. KOSTIN
National Medical Research Radiological Center of the Ministry of Health of Russia, Moscow
Russian Federation
MD, Prof.


N. V. VOROBYEV
National Medical Research Radiological Center of the Ministry of Health of Russia, Moscow
Russian Federation
PhD in medicine


S. V. POPOV
National Medical Research Radiological Center of the Ministry of Health of Russia, Moscow
Russian Federation
PhD in medicine


References

1. Практическая урология. Под ред. Глыбочко П.В., Аляева Ю.Г. М.: ИД «Медфорум», 2012. 352 с. / Practical Urology. Ed. By Glybochko P.V., Alyaeva Y.G., M.: Publishing House Medforum, 2012. 352 p.

2. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. Под ред. Аляева Ю.Г., Аполихина О.И., Пушкаря Д.Ю., Козлова Р.С., Камалова А.А., Перепановой Т.С. М., 2015. 72 с. / Antimicrobial therapy and prevention of infections of kidneys, urinary tracts and male genital organs. Federal Clinical Recommendations. Ed. By Alyaev Y.G., Apolikhin O.I., Pushkar D.Y., Kozlov R.S., Kamalov A.A., Perepanova T.S. M., 2015, 72 p.

3. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена. 2016. 250 с. / Malignant legions in Russia in 2014 (morbidity and death rate). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. M: Hertsen Moscow Scientific and Research Oncology Institute. 2016. 250 p.

4. Набер К. Г., Бишоп М. С., Бьерклунд-Йохансен Т. Е., Ботто Х., Сек М., Грабэ М., Лобел Б., Палоу Дж., Тенке П. Рекомендации по ведению больных с инфекциями почек, мочевых путей и мужских половых органов. Смоленск, 2008. 224 с. / Naber K.G., Bishop M.S., Bjerklund-Johansen T.E., Botto H., Sek M., Grabe M., Lobel B., Palou J., Tenke P. Recommendations on management of patients with infections of kidneys, urinary tracts and male genital organs. Smolensk, 2008. 224 p.

5. Сидоренко С.В. Микробиологическая характеристика инфекций мочевыводящих путей. Материалы международного симпозиума: «Инфекции мочевыводящих путей в амбулаторной практике» 16 февраля 1999 г. М.,1999. C. 9-14. / Sidorenko S.V. Microbiological characteristics of infections of urinary tracts. Materials of international symposium: Urinary Tract Infections in Outpatient Practice, February 16, 1999, M., 1999. P. 9-14.

6. Naber KG, Morrissey I, Ambler JE. Urinary Tract Infections and Fluoroquinolones. Science Press Ltd, 2000.


Review

For citations:


KAPRIN AD, KOSTIN AA, VOROBYEV NV, POPOV SV. STARTING ANTIMICROBAL PYELONEPHRITIS THERAPY BEFORE SURGICAL THERAPY OF THE URINARY BLADDER THERAPY. Meditsinskiy sovet = Medical Council. 2016;(9):92-95. (In Russ.) https://doi.org/10.21518/2079-701X-2016-9-92-95

Views: 589


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)